| Old Articles: <Older 1201-1210 Newer> |
|---|
 |
The Motley Fool
May 24, 2004
Brian Gorman |
Abbott Labs Stirs Up Criticism With politicians and the public riled up about Medicare, Abbott hiked the cost of an HIV drug. Smart move?   |
BusinessWeek
May 31, 2004
Michael J. Mandel |
The Health-Care Catastrophe That Won't Happen Why biotech gains will rein in medical costs. The lesson of info tech. |
BusinessWeek
May 31, 2004
Robert Barker |
Hospira Just May Put You In The Pink If the Abbott Laboratories spin-off's first steps hardly seem promising, that's one reason why I see the company as worth much more of the intelligent investor's attention than the long calendar of pending tech and biotech IPOs. |
The Motley Fool
May 21, 2004
Charly Travers |
Protein Design Labs' Mixed Results Protein Design Labs' Nuvion looks like a winner, while other drugs stumble. Nuvion is in early clinical development for the treatment of severe ulcerative colitis and so far the results seem particularly compelling. |
Bio-IT World
May 19, 2004
Malorye Branca |
Attack of the Lab-Bots Robots are invading every aspect of discovery and development within pharmaceutical companies, from genotyping to high-throughput screening. |
Bio-IT World
May 19, 2004
Mark Uehling |
Patients Without Borders As biotech companies search for patients abroad, technology clearly matters--but not every clinical trial on the planet is ready for electronic data capture. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Turning Sugar into Science The landmark building that housed the New England Confectionery Company in Revere, Mass. is being transformed into the new headquarters for the Novartis Institutes for BioMedical Research. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Biotech Off the Beaten Track Lexicon Genetics wants to help put Texas on the biotech map. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Surging in Seattle Laid-back coastal-mountain lifestyle bolsters Northwestern biotech company. |
Bio-IT World
May 19, 2004
John Russell |
Informatics Black Boxes ... Not! Vertex's chief technical officer, discusses informatics' bad reputation, buying vs. building, open-source tools, and ROI on IT. |
| <Older 1201-1210 Newer> Return to current articles. |
